Free tool
FAERS Monitor: Selzentry
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 208984 or its brand name (Selzentry, Maraviroc). Reports on generic versions are filed under their own applications.
Reports
2,293
Serious
1,961
86% of reports
Hospitalization
825
Death reported
264
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- virologic failure141
- viral mutation identified128
- pathogen resistance125
- pain95
- anxiety94
- off label use94
- drug ineffective93
- drug interaction86
- drug resistance85
- emotional distress73
- nausea73
- treatment failure64
- anhedonia62
- exposure during pregnancy62
- treatment noncompliance57
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2007 | 11 |
| 2008 | 86 |
| 2009 | 151 |
| 2010 | 164 |
| 2011 | 138 |
| 2012 | 156 |
| 2013 | 124 |
| 2014 | 120 |
| 2015 | 140 |
| 2016 | 185 |
| 2017 | 133 |
| 2018 | 128 |
| 2019 | 108 |
| 2020 | 118 |
| 2021 | 140 |
| 2022 | 120 |
| 2023 | 124 |
| 2024 | 64 |
| 2025 | 49 |
| 2026 | 34 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,866 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| viral mutation identifiedSignal | 128 | 330.2 | 278.2 | 40,241 |
| virologic failureSignal | 141 | 246.9 | 210.0 | 33,403 |
| pathogen resistanceSignal | 125 | 127.5 | 107.4 | 15,359 |
| drug resistanceSignal | 85 | 30.5 | 24.7 | 2,387 |
| anhedoniaSignal | 62 | 21.7 | 17.0 | 1,202 |
| treatment noncomplianceSignal | 57 | 9.6 | 7.4 | 429 |
| exposure during pregnancySignal | 62 | 9.2 | 7.2 | 443 |
| treatment failureSignal | 64 | 7.1 | 5.6 | 330 |
| emotional distressSignal | 73 | 5.5 | 4.4 | 268 |
| drug interactionSignal | 86 | 5.0 | 4.0 | 271 |
| anxietySignal | 94 | 3.0 | 2.5 | 128 |
| pain | 95 | 1.4 | 1.2 | 12 |
| off label use | 94 | 1.0 | 0.8 | 0 |
| nausea | 73 | 0.8 | 0.7 | 2 |
| drug ineffective | 93 | 0.6 | 0.5 | 19 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.